What Scientists Discovered
UCLA scientists found a group of immune cells that quietly gather in old tissues and in livers affected by fatty liver disease. When these cells were taken away from mice, the inflammation dropped a lot and the liver started to heal, even though the mice kept eating a bad diet.
What Are "Zombie" Cells?
These cells are called “senescent” or “zombie” cells. They stop dividing but do not die. Instead, they keep sending out inflammatory signals that can hurt nearby cells.
Finding the Real Culprit
For a long time, scientists were not sure if macrophages – the body’s clean‑up crew – could become senescent. Healthy macrophages already look a bit like senescent cells, so it was hard to tell them apart.
The UCLA team solved the puzzle by spotting two proteins, p21 and TREM2, that together mark truly senescent macrophages. Using this marker, they saw a big change with age: only about 5% of liver macrophages were senescent in young mice, but 60‑80% were senescent in older mice. This matched the rise in liver inflammation.
Cholesterol Can Push Cells Over the Edge
Too much cholesterol also makes macrophages turn senescent. In lab tests, healthy macrophages exposed to high LDL stopped dividing, released inflammatory proteins, and showed the p21‑TREM2 signature.
This suggests that high‑fat, high‑cholesterol diets may speed up aging in many organs, not just the liver.
Removing Senescent Cells Helps Mice
To see if getting rid of these cells could improve health, researchers gave mice a drug called ABT‑263 that selectively kills senescent cells. The results were striking.
- Liver size fell from about 7% of body weight to a healthier 4‑5%.
- Body weight dropped about 25%, from roughly 40 g to 30 g.
- Livers looked smaller, red, and normal instead of enlarged and yellow.
One researcher said, “Removing senescent cells doesn’t just slow fatty liver—it actually reverses it.”
Do Humans Show the Same Pattern?
Researchers checked a public dataset of human liver biopsies. They found the same senescent‑macrophage signature was much higher in diseased livers than in healthy ones. This means the same process may happen in people.
In Los Angeles, up to 40% of residents have fatty liver disease, with even higher rates in Latino communities. Treatment options are limited, and early detection tools are scarce.
Looking Ahead to Safer Treatments
ABT‑263 works in mice but is too toxic for people. The team will now search for safer compounds that can clear senescent macrophages without harmful side effects.
They are also exploring whether similar senescent processes occur in other age‑related diseases, such as Alzheimer’s (where brain macrophages called microglia may become senescent).
Why It Matters
The study supports the idea that one aging process can drive many diseases. If we learn how senescent macrophages cause inflammation, we might treat not only fatty liver disease but also atherosclerosis, Alzheimer’s, and cancer.